Updated on 18 February 2015
IAVI proposes to develop safe, effective, accessible, preventive HIV vaccines for use throughout the world
Singapore: In a bid to curb AIDS and support the development of vaccines, GSK has donated a sum of $350,000 to International AIDS Vaccine Initiative group. The GSK grant will help in establishing the project's global consortium and execute its research program, said sources.
The GSK grant was announced in a symposium at the AAAS 2015 Annual Meeting in San Jose, CA, by Mr Wayne C Koff, IAVI chief scientific officer and founding member of the Human Vaccines Project Board.
Mr Emmanuel Hanon, senior vice president, Vaccines Research and Development, GSK, said, "We are very pleased to support the Human Vaccines Project and we encourage others to join us in this potentially ground-breaking initiative."
The project aims to address the common scientific hurdles preventing the development of vaccines against major and emerging infectious diseases and cancers complementing ongoing disease-specific vaccine development efforts.
"The Human Vaccine Project will help in tackling global killers such as AIDS, TB, malaria, Ebola, and cancers. Science and innovation will get us the vaccines we need," said Mr Stanley Plotkin, Emeritus Professor of the University of Pennsylvania and chairman of the Human Vaccines Project Steering Committee.